Axel Ullrich

Person

Martimiried, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Method for treatment of diabetes by a small molecule inhibitor for...
- Patent number 9,458,463
- Issue date Oct 4, 2016
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Mathias Falcenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline derivatives as AXL kinase inhibitors
- Patent number 9,206,130
- Issue date Dec 8, 2015
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinolinyloxyphenylsulfonamides
- Patent number 9,169,241
- Issue date Oct 27, 2015
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of her3 activity
- Patent number 9,011,851
- Issue date Apr 21, 2015
- Max-Planck Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutically active compounds as Axl inhibitors
- Patent number 8,999,982
- Issue date Apr 7, 2015
- Lead Discovery Center GmbH
- Carsten Schultz-Fademrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinolinyloxyphenylsulfonamides
- Patent number 8,685,971
- Issue date Apr 1, 2014
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibition of TACE or amphiregulin for the modulation of EGF recept...
- Patent number 8,591,903
- Issue date Nov 26, 2013
- Max-Planck Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diagnosis and prevention of cancer cell invasion
- Patent number 8,277,802
- Issue date Oct 2, 2012
- Max-Planck-Gesellschaft zur Foederung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of diagnosing an RTK-hyperfunction induced disorder
- Patent number 8,043,806
- Issue date Oct 25, 2011
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell line comprising vector encoding truncated FLK-1 receptor
- Patent number 7,964,399
- Issue date Jun 21, 2011
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of inhibitors for the treatment of RTK-hyperfunction-induced di...
- Patent number 7,678,372
- Issue date Mar 16, 2010
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGF receptor transactivation by G-protein-coupled receptors require...
- Patent number 7,632,645
- Issue date Dec 15, 2009
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for screening FGFR-4 agonists
- Patent number 7,531,304
- Issue date May 12, 2009
- Max-Planck Gesellschaft zur Foerderung der Wissenschaften e.V.
- Johannes Bange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of TACE or amphiregulin for the modulation of EGF recept...
- Patent number 7,524,495
- Issue date Apr 28, 2009
- Max-Planck Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Extracellular signal-regulated kinase sequences and methods of prod...
- Patent number 7,371,828
- Issue date May 13, 2008
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Cornelia Lechner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inhibitors for the treatment of RTK-hyperfunction-induced di...
- Patent number 7,297,774
- Issue date Nov 20, 2007
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding BDP-1
- Patent number 7,074,589
- Issue date Jul 11, 2006
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Receptor-type phosphotyrosine phosphatase-kappa antibodies
- Patent number 7,056,508
- Issue date Jun 6, 2006
- New York University
- Joseph Schlessinger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Megakaryocytic protein tyrosine kinase I
- Patent number 7,037,677
- Issue date May 2, 2006
- Sugen, Inc.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies directed against signal regulator proteins
- Patent number 6,913,894
- Issue date Jul 5, 2005
- Eberhard-Karls Universität Tübingen Universitätsklinikum
- Hans-Jörg Bühring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MCK-10 a novel receptor tyrosine kinase
- Patent number 6,897,029
- Issue date May 24, 2005
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Truncated Flk-1 receptor protein, methods of use and a recombinant...
- Patent number 6,872,699
- Issue date Mar 29, 2005
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding CLK2 protein kinases
- Patent number 6,797,513
- Issue date Sep 28, 2004
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Protein tyrosine phosphatase PTP20 and related products and methods
- Patent number 6,797,501
- Issue date Sep 28, 2004
- Max-Planck-Gessellschaft zur Fonderung de Wissenschaften E.V.
- Naohita Aoki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inhibitors for the treatment of disorders related to RTK hyp...
- Patent number 6,770,742
- Issue date Aug 3, 2004
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Extracellular signal-regulated kinase, sequences, and methods of pr...
- Patent number 6,579,972
- Issue date Jun 17, 2003
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
- Cornelia Lechner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PTP 1D: a novel protein tyrosine phosphatase
- Patent number 6,548,641
- Issue date Apr 15, 2003
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
SIRP proteins and uses thereof
- Patent number 6,541,615
- Issue date Apr 1, 2003
- Max-Planck-Gellschaft zur Foderung der Wissenschaften E.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PTP-S31: a novel protein tyrosine phosphatase
- Patent number 6,492,495
- Issue date Dec 10, 2002
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Niels Peter Hundahl Moller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Protein tyrosine phosphatase PTP20 and related products and methods
- Patent number 6,482,605
- Issue date Nov 19, 2002
- Sugen, Inc.
- Naohito Aoki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY
- Publication number 20150079108
- Publication date Mar 19, 2015
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Mathias Falcenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
QUINOLINYLOXYPHENYLSULFONAMIDES
- Publication number 20140336191
- Publication date Nov 13, 2014
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS
- Publication number 20140018365
- Publication date Jan 16, 2014
- MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCCHAFTEN E.V.
- Carsten Schultz-Fademrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY
- Publication number 20130336986
- Publication date Dec 19, 2013
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Mathias Falcenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DIAGNOSIS AND PREVENTION OF CANCER CELL INVASION
- Publication number 20130084300
- Publication date Apr 4, 2013
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.v
- Axel ULLRICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
QUINOLINYLOXYPHENYLSULFONAMIDES
- Publication number 20120277231
- Publication date Nov 1, 2012
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM
- Publication number 20110179505
- Publication date Jul 21, 2011
- MAX-PLANCK-GESELLSCHAGFT zur FOERDERUNG der WISSENSCHAFTEN e.V.
- Axel Ullrich
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS
- Publication number 20110092503
- Publication date Apr 21, 2011
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HER3 AS A DETERMINANT FOR THE PROGNOSIS OF MELANOMA
- Publication number 20110033482
- Publication date Feb 10, 2011
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER-RELATED PROTEIN KINASES
- Publication number 20110008347
- Publication date Jan 13, 2011
- AGENCY FOR SCIENCE ,TECHNOLOGY AND RESEARCH
- Axel Ullrich
- G01 - MEASURING TESTING
Information Patent Application
USE OF INHIBITORS FOR THE TREATMENT OF RTK-HYPERFUNCTION-INDUCED DI...
- Publication number 20100184686
- Publication date Jul 22, 2010
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeut...
- Publication number 20100143386
- Publication date Jun 10, 2010
- Max-Planck-Gesellschaft zur foerderung der Wissenschaften, e. V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRE...
- Publication number 20100048684
- Publication date Feb 25, 2010
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibition of TACE or amphiregulin for the Modulation of EGF Recept...
- Publication number 20090292007
- Publication date Nov 26, 2009
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR AGONISTS
- Publication number 20090123462
- Publication date May 14, 2009
- Johannes Bange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Products and methods for treating PTP lar diseases
- Publication number 20090074722
- Publication date Mar 19, 2009
- MAX-PLANCK-GESELLSCHAFT ZUR
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related produ...
- Publication number 20080051556
- Publication date Feb 28, 2008
- Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRUVATE-KINASE AS A NOVEL TARGET MOLECULE
- Publication number 20080021116
- Publication date Jan 24, 2008
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- G01 - MEASURING TESTING
Information Patent Application
Novel megakaryocytic protein tyrosine kinase 1
- Publication number 20060263877
- Publication date Nov 23, 2006
- SUGEN, INC.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of tace or amphiregulin for the modulation of egf recept...
- Publication number 20060246448
- Publication date Nov 2, 2006
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of stress-induced ligand-dependent egfr activation
- Publication number 20060148694
- Publication date Jul 6, 2006
- Max-Planck-Gesellschaft zur Foerderung der Wessenschaften. E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA encoding MCK-10, a novel receptor tyrosine kinase
- Publication number 20060147372
- Publication date Jul 6, 2006
- Max-Planck-Gesellschaft zur Foederung der Wissenschaften
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diagnosis and prevention of cancer cell invasion
- Publication number 20050186571
- Publication date Aug 25, 2005
- Max-Planck-Gesellschaft zun
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of egfr transactivation inhibitors in human cancer
- Publication number 20050176633
- Publication date Aug 11, 2005
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fgfr agonists
- Publication number 20050153878
- Publication date Jul 14, 2005
- Johannes Bange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLK-1 is a receptor for vascular endothelial growth factor
- Publication number 20050107321
- Publication date May 19, 2005
- SUGEN, INC. and MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLK protein kinases and related products and methods
- Publication number 20040259220
- Publication date Dec 23, 2004
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of inhibitors for the treatment of RTK-hyperfunction-induced di...
- Publication number 20040235776
- Publication date Nov 25, 2004
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of her3 activity
- Publication number 20040197332
- Publication date Oct 7, 2004
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyruvate-kinase as a novel target molecule
- Publication number 20040152648
- Publication date Aug 5, 2004
- Axel Ullrich
- G01 - MEASURING TESTING

Axel Ullrich

Person

Patents Grantslast 30 patents

Method for treatment of diabetes by a small molecule inhibitor for...

Quinoline derivatives as AXL kinase inhibitors

Quinolinyloxyphenylsulfonamides

Inhibitors of her3 activity

Pharmaceutically active compounds as Axl inhibitors

Quinolinyloxyphenylsulfonamides

Inhibition of TACE or amphiregulin for the modulation of EGF recept...

Diagnosis and prevention of cancer cell invasion

Method of diagnosing an RTK-hyperfunction induced disorder

Cell line comprising vector encoding truncated FLK-1 receptor

Use of inhibitors for the treatment of RTK-hyperfunction-induced di...

EGF receptor transactivation by G-protein-coupled receptors require...

Method for screening FGFR-4 agonists

Inhibition of TACE or amphiregulin for the modulation of EGF recept...

Extracellular signal-regulated kinase sequences and methods of prod...

Use of inhibitors for the treatment of RTK-hyperfunction-induced di...

Nucleic acids encoding BDP-1

Receptor-type phosphotyrosine phosphatase-kappa antibodies

Megakaryocytic protein tyrosine kinase I

Antibodies directed against signal regulator proteins

MCK-10 a novel receptor tyrosine kinase

Truncated Flk-1 receptor protein, methods of use and a recombinant...

Nucleic acid encoding CLK2 protein kinases

Protein tyrosine phosphatase PTP20 and related products and methods

Use of inhibitors for the treatment of disorders related to RTK hyp...

Extracellular signal-regulated kinase, sequences, and methods of pr...

PTP 1D: a novel protein tyrosine phosphatase

SIRP proteins and uses thereof

PTP-S31: a novel protein tyrosine phosphatase

Protein tyrosine phosphatase PTP20 and related products and methods

Patents Applicationslast 30 patents

KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY

QUINOLINYLOXYPHENYLSULFONAMIDES

PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS

KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY

DIAGNOSIS AND PREVENTION OF CANCER CELL INVASION

QUINOLINYLOXYPHENYLSULFONAMIDES

RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM

QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS

HER3 AS A DETERMINANT FOR THE PROGNOSIS OF MELANOMA

CANCER-RELATED PROTEIN KINASES

USE OF INHIBITORS FOR THE TREATMENT OF RTK-HYPERFUNCTION-INDUCED DI...

FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeut...

EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRE...

Inhibition of TACE or amphiregulin for the Modulation of EGF Recept...

FGFR AGONISTS

Products and methods for treating PTP lar diseases

Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related produ...

PYRUVATE-KINASE AS A NOVEL TARGET MOLECULE

Novel megakaryocytic protein tyrosine kinase 1

Inhibition of tace or amphiregulin for the modulation of egf recept...

Inhibition of stress-induced ligand-dependent egfr activation

DNA encoding MCK-10, a novel receptor tyrosine kinase

Diagnosis and prevention of cancer cell invasion

Use of egfr transactivation inhibitors in human cancer

Fgfr agonists

FLK-1 is a receptor for vascular endothelial growth factor

CLK protein kinases and related products and methods

Use of inhibitors for the treatment of RTK-hyperfunction-induced di...

Inhibitors of her3 activity

Pyruvate-kinase as a novel target molecule